Pirfenidone: A Novel Anti-fibrotic Agent and Progressive Chronic Allograft Rejection

By Dosanjh A.   Ikonen T.   Wan B.   Morris R.E.  

Pulmonary Pharmacology & Therapeutics, Vol. 15, Iss. 5, 2002-10 ,pp. : 433-437

Academic Press

Access to resources Recommend Favorite

A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor- at the translational level

By Nakazato H.   Oku H.   Yamane S.   Tsuruta Y.   Suzuki R.  

European Journal of Pharmacology, Vol. 446, Iss. 1, 2002-06 ,pp. : 177-185

Elsevier

Access to resources Recommend Favorite

CCN2: a novel, specific and valid target for anti-fibrotic drug intervention

By Leask Andrew  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 9, 2013-09 ,pp. : 1067-1071

Informa Healthcare

Access to resources Recommend Favorite

Anti-fibrotic effects of tetrandrine on bile-duct ligated rats

By Hsu Yi-Chao   Chiu Yung-Tsung   Lee Chang-Yin   Wu Ching-Fen   Huang Yi-Tsau  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 10, 2006-10 ,pp. : 967-976

NRC Research Press

Access to resources Recommend Favorite

Tissue Protective and Anti-Fibrotic Actions of Suramin: New Uses of an Old Drug

By  

Current Clinical Pharmacology, Vol. 6, Iss. 2, 2011-05 ,pp. : 137-142

Bentham Science Publishers

Access to resources Recommend Favorite